Advertisement

Topics

Aduro Biotech Names Andrea van Elsas Successor to CSO Thomas Dubensky

19:12 EDT 28 Jul 2017 | Xconomy

Aduro Biotech (NASDAQ: ADRO) chief scientific officer Thomas Dubensky is leaving to run his own discovery and research company, according to the cancer immunotherapy developer. Berkeley, CA-based Aduro says Dubensky’s resignation will be effective Aug. 31. He had served as Aduro’s chief scientific officer since 2011. Andrea van Elsas, currently CSO of Aduro Biotech Europe, […]

Original Article: Aduro Biotech Names Andrea van Elsas Successor to CSO Thomas Dubensky

NEXT ARTICLE

More From BioPortfolio on "Aduro Biotech Names Andrea van Elsas Successor to CSO Thomas Dubensky"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...